As of Feb 03, 2025, Hims & Hers Health, Inc.'s Discounted Cash Flow (DCF) valuation estimates its share price at N/A. This suggests it may be overvalued by (100.0%) compared to its current price of around $38.9, using a WACC of 9.4% and growth rates of 2.0%.
As of Feb 03, 2025, Hims & Hers Health, Inc.'s Weighted Average Cost of Capital (WACC) is approximately 9.4%.
As of Feb 03, 2025, Hims & Hers Health, Inc.'s Enterprise Value (EV) is approximately $0.0. This value reflects the company's total market capitalization plus debt, minus cash and cash equivalents, providing a comprehensive measure of its overall value in the market.